Efficacy and Safety Study of XP12B in Women With Menorrhagia

• Status: Completed
• Trial end date: 2008-05-01
• Target enrollment: 0
• Participant gender: Female

Summary

The purpose of this study is to determine whether XP12B is effective and safe in the treatment of women with heavy menstrual bleeding associated with menorrhagia.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Ferring Pharmaceuticals
• Treatments: Tranexamic Acid

Criteria

Inclusion Criteria:

• Women with menorrhagia

• 18-49 years of age

• Regularly occurring menstrual periods

Exclusion Criteria:

• History or presence of clinically significant disease or abnormalities that may confound the study

• History of bilateral oophorectomy or hysterectomy

• Hormone therapy